Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January – June 2019

Profitability and acquisitions ahead of planApril – June January – June 20192019 ·  Net sales increased by 21.9 percent to SEK 2,624 (2,153) ·  Net million. Organic growth was 2.0 (8.5) percent.sales ·  Adjusted EBITA increased to SEK 215 (180) million, whichincreased by corresponds to an adjusted EBITA margin of 8.2 (8.4) percent.19.8 percent ·  Operating cash flow for the period was SEK 282 (231)to SEK 1,406 million.(1,174) ·  Eight acquisitions were made during the first half of themillion. year, which, on an annual basis

Enersize publishes the interim report for the first six months 2019

This is a translation of previously released news. Enersize Oyj ("Enersize" or the "Company") hereby submits a half-year report for the period January – June 2019. · Enersize develops and sells the cloud services LEAQS and Q+ for the improvement of energy efficiency of industrial compressed air systems for the global manufacturing industry. · Enersize has implemented radical changes in the company and has now begun an expansion with a new business model that has been confirmed by several new orders, most recently with one of Hankook's factories in China. · Enersize's turnover in H1

Exercise period for BrainCool’s warrants, TO3 2019-2022, 26 August – 9 September 2019

As part of our agreement with L1 Capital, BrainCool has distributed free warrants to the company's shareholders to reduce dilution. During the period of August 26 to September 9, 2019, holders of TO3 Warrants can exercise the Warrants and subscribe for new shares. One (1) TO3 can be exchanged for one (1) share during the period, at a price of SEK 7.00. In total BrainCool would receive approximately SEK 8,4 million if all Warrants of series TO3 were to be exercised. Holders of warrants who have their Warrants registered in custody at a bank or fund commissioner shall contact their

Heimstaden AB considers issuance of hybrid bonds

Heimstaden AB (publ) (the “Company” or “Heimstaden”) has mandated Nordea and Swedbank as joint bookrunners to arrange investor meetings to investigate the possibility to issue hybrid bonds under the Company’s existing hybrid bond loan (ISIN SE0012455111). The hybrid bond loan has an outstanding amount of SEK 2,000,000,000, a framework amount of SEK 5,000,000,000 and a perpetual maturity with a Company’s first call date in approximately 5 years. Proceeds from the contemplated issue are to be used for general corporate purposes [including acquisitions within both Heimstaden and Heimstaden

The Museum of Fossil Fuels opens in Sweden – "A fossil-free life is soon a reality"

Sweden often tops global sustainability rankings. Now, the world's first fossil fuel museum is opening in the country. "The shift will go much faster than we think, especially in the area of transportation, and fossil-fuels will be a thing of the past," says Susanna Hurtig, Nordic Head of InCharge at Vattenfall, the power company that is initiator of the museum.In 2019, the sound of combustion engines, the scent of petrol and filling your fuel tank at your local petrol station are still normal everyday occurrences for most people. But not for much longer. The demand for emissions-free

OxThera receives positive decision from EMA on Paediatric Investigational Plan (PIP) for treatment of primary hyperoxaluria with Oxalobacter formigenes

STOCKHOLM, SWEDEN – August 23, 2019. OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), today announced that, based on a positive opinion from the Paediatric Committee (PDCO), the EMA has agreed to the proposed PIP for Oxalobacter formigenes in the treatment of primary hyperoxaluria.“We are pleased to announce this important regulatory milestone. The approval of the Paediatric Investigational Plan provides us with a clear development path for Oxabact in the treatment of paediatric patients with primary

Become an integration expert!

[] Date: September 19, 2019 We're excited to announce our upcoming integration event, the iCore Bootcamp. Expand your iCore knowledge and update yourself on the latest technical features and performance in iCore Integration Suite and iCore Cloud Services. The event is scheduled to take place in Göteborg on the 17th of September and in Stockholm on September the 19th.  Make sure to note the date in your calendar right now!  Read more and sign up for the event - iCore Bootcamp. 

Epiroc to expand production facility in Örebro, Sweden

Stockholm, Sweden: Epiroc, a leading productivity provider for the mining and infrastructure industries, will expand one of its main production facilities, in Örebro, Sweden, to boost productivity and ensure long-term efficiency.Epiroc will expand and consolidate its production capacity utilized by the Surface and Exploration Drilling division, including constructing a major new building hosting assembly and offices. Production efficiency will be strengthened in the process. In total, it involves a facility expansion of about 10,000 square meters. Construction will begin this year and the

NENT Group calls ‘First Responders’ to first original medical drama series

· Ten-part series to premiere exclusively on Viaplay in 2020 · ‘First Responders’ produced by SF Studios · NENT Group to premiere at least 20 original productions every year The Swedish medical drama series ‘First Responders’ will be the next original production from Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company. Filmed in the scenic Swedish mountain village of Åre, the 10-part series will premiere exclusively on NENT Group’s Viaplay streaming service across the Nordic region in 2020. ‘First Responders’ (Swedish title: ‘Åreakuten’)

BE Group changes Chairman of the Board in conjunction with Peter Andersson taking office as CEO on October 1, 2019

The Board of BE Group will, within short, convene an Extraordinary General Meeting to be held on September 18 in order to change the Chairman of the Board. The change, aligned with the Nomination Committee, will mean that Jörgen Zahlin replaces current Chairman, Petter Stillström, who will assume the role as regular Board member. Jörgen Zahlin, born 1964, is CEO of OEM International and has been a member of the BE Group Board of Directors since 2013.The Board of Directors has also decided that Peter Andersson will take office as new CEO of BE Group on October 1, 2019. I have, in my

Tikkurila's financial reporting and Annual General Meeting in 2020

Tikkurila OyjStock Exchange ReleaseAugust 23, 2019 at 10:00 a.m. (CET+1) Tikkurila's financial reporting and Annual General Meeting in 2020 Tikkurila Oyj will publish its financial statement release, half year financial report and two business reviews in 2020 as follows: - February 12, 2020: Financial statement release for 2019- April 29, 2020: Business review for January-March 2020- July 24, 2020: Half year financial report for January-June 2020- October 29, 2020: Business review for January-September 2020 Tikkurila observes a silent period of 30 days before it

HALF YEAR FINANCIAL REPORT 2019

[] Press release: Stockholm, August 23, 2019, 8,45 am SECOND QUARTER 2019 ·Revenue was 30 MSEK (0) ·Net profit was -35 MSEK (-8) ·Earnings per share was -0,26 SEK (-0,06) ·The first concentrate delivery was made on April 8th ·Erkki Kuronen, head of geology and mining, was appointed Managing Director of Sotkamo Silver Oy ·The Board resolved to a directed share issue of 4.2 million shares at 3,60 SEK and an issue of a convertible bond of 15 million SEK. HALF YEAR 2019 ·Cash flow from operating activities was -32 MSEK (4) ·

NOTICE OF EXTRAORDINARY GENERAL MEETING OF BIOSERVO TECHNOLOGIES AB (PUBL)

The shareholders in Bioservo Technologies AB (publ), 556650-7264 (the “Company”), are invited to attend the Extraordinary General Meeting at the Company’s facilities, Torshamnsgatan 35, Kista, Sweden, on Tuesday, September 10, 2019 at 10.00 (CET).Right to participate and notification Shareholders who wish to participate in the extraordinary general meeting must 1. be recorded in the Shareholders' Register issued by Euroclear Sweden AB on Wednesday, September 4, 2019, 2. no later than Wednesday, September 4, 2019 notify the Company of participation including the number of assistants

2cureX publishes half-year report for the first half of 2019

2cureX AB (“2cureX”) hereby publishes the half-year report for the first half of 2019. The half-year report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a short summary of the report.CEO Ole Thastrup commentsThe second financial quarter of 2019 has as usual meant a high level of activity at 2cureX. We have focused specifically on the commercial aspect of our business by introducing pre-launch activities, as we get closer to the launch of IndiTreat® as a commercial product. Initial talks with oncologists in Germany and the Nordics

H1 2019 report

Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016.  +--------------------------------------------+|Second Quarter (2019-04-01 – 2019-06-30) |+--------------------------------------------+| || · Net revenues were TDKK 0 (0) || · EBIT was TDKK -3,404 (-3,294) || · Earnings per share was DKK –0.15 (-0.19)|+--------------------------------------------+|

Interim Financial Report January – June 2019

We have during the first half of 2019 seen that the activities we have undertaken to create a better underlying profitability, by reviewing the product portfolio and increasing the efficiency in our production, are paying off. EBITDA excl. IFRS 16 increased by 44% compared to the first six months last year. LEAX has during the period continued the large investment program for the passenger car segment and has invested about SEK 110 million during the first half of the year. We have at the end of the second quarter made the first series deliveries for one of the projects. The outlook

Cantargia and BioWa extend ongoing collaboration around the POTELLIGENT® Technology

Lund, Sweden, and Princeton, NJ, USA, August 23, 2019 ---Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENT® Technology for production of Cantargia’s antibody drug candidate CAN04, which gives Cantargia broader rights to use the technology. Since the original agreement allowing use of POTELLIGENT® Technology was signed in 2015, Cantargia has advanced CAN04 to phase IIa clinical development for potential use in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer (PDAC).Cantargia develops antibody-based

Bioservo Technologies AB intends to carry out a Rights Issue to accelerate the company’s commercial efforts

The Board of Directors of Bioservo Technologies AB (publ), org. nr 556650-7264 (”Bioservo” or the ”Company”), has on August 23, 2019, subject to the approval by an Extraordinary General Meeting, decided to carry out a Rights Issue of 64.3 MSEK by issuing, at the most, 5 361 870 shares implying an increase of the Company’s Share Capital with 1 072 374 SEK (the ”Rights Issue”).Background and purpose The market for exoskeletons is about to expand dramatically and it is vital for Bioservo that the company’s technology and solutions are accepted and adopted in the marketplace.  To achieve

Smart Eye interim report January – June 2019

Continued progress – New design winApril – June 2019 · Net sales totalled SEK 12,378 (11,004) thousand which corresponds to a rise of 12 %. · Operating profit/loss totalled SEK -24,669 (-16,764) thousand, Earnings are developing according to plan and are still affected by measures taken to meet higher demand above all from customers in the Automotive Solutions business area. In addition, the efforts to meet increased demand from the Chinese market has also affected the cost level. · Profit/loss after financial items was SEK -24,803 (-16,764) thousand · Profit/loss after tax

Nordic Mining ASA (OAX:NOM) - Interim report per 30 June 2019

Enclosed please find Nordic Mining’s interim report and company presentation for the second quarter of 2019. The interim report and company updates will be presented today, Friday 23 August 2019 at 10.00 (CET) in the company’s office (address details below). A presentation and Q&A session will be held in English and transferred via webcast (details for the webcast below). Important events in the second quarter of 2019 and year-to-date:ENGEBØ RUTILE AND GARNET PROJECT (100% ownership) ·  Additional milestones reached in the definitive feasibility study In August, the mining

Insplorion sells an Acoulyte instrument to Kao Corporation for their research and development within cleaning agents

The R&D department at Kao Corporation, a chemical and cosmetics multinational company headquartered in Japan, has purchased an Acoulyte instrument. This is the first sale of Insplorion instruments in Japan and was realized by Insplorion’s Japanese distributor Meiwafosis. The list price for Acoulyte is over € 40 000 from which standard distributor discount has been applied.Kao corporation is a chemical and consumer products corporation with 33 000 employees and a turnover of almost € 13 billion, with main business areas within household cleaning products, personal hygiene and cosmetics. The

Enea completes a directed share issue of SEK 271 million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF ANY SECURITIES OF ENEA.Stockholm, Sweden, August 23, 2019 Enea® (Nasdaq Stockholm: ENEA) Enea AB (publ) (“Enea”) has, as indicated by Enea in its press release on 22 August 2019, resolved to make a directed share issue of 1,965,000 shares at a subscription price of SEK 138 per share. Enea will thereby obtain issue

Heliospectra AB (publ) Half Year Report January – June 2019

(GOTHENBURG, Sweden/SAN FRANCISCO, CA, Aug 23, 2019 – Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, today presents the Half Year Report for 2019.TURNOVER AND PROFIT/LOSS JANUARY – JUNE · Net sales amounted to SEK 16,744 (17,324) thousand  · Order intake amounted to SEK 18,111 (30,309) thousand  · Operating profit/loss amounted to SEK -20,842 (-16,625) thousand  · Profit/loss after tax was SEK -20,945 (-16,476) thousand or SEK -0.45 (-0.47) per share

Construction of new community centre starting in Kerava, Finland – Caverion to implement building systems

Caverion Corporation Investor news 23 August 2019 at 9:00 a.m. EESTConstruction of new community centre starting in Kerava, Finland – Caverion to implement building systems Caverion will deliver building systems for the Keravanjoki community centre. The client of the project is the City of Kerava, and it will be implemented through an alliance model. Caverion will be responsible for the Total Technical Solutions, covering all building systems for the community centre. The value of the agreement is EUR 7.6 million. The Keravanjoki community centre project is implemented

There are no items matching the current filter
There are no more items matching the current filter
Back to top